Gastric Volume After Ingestion of Carbohydrate Drink vs Water in Obese Volunteers

April 21, 2023 updated by: Chanatthee Kitsiripant, Prince of Songkla University

Comparison of Gastric Residual Volume After Ingestion of Carbohydrate Drink and Water in Obese Volunteers: A Randomized Crossover Study

This randomized crossover study compares gastric residual volume after ingestion of carbohydrate drinks and water in obese volunteers. The main question[s] it aims to answer are:

  • Is it safe for obese patients to shorten their fasting by allowing preoperative drinks?
  • How long is the gastric emptying time in obese patients? Participants also will be evaluated the level of thirst/hungry and blood sugar.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Songkhla, Thailand, 90110
        • Department of Anesthesiology, Faculty pf Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy volunteers
  • Age 18 - 65 years old
  • BMI ≥ 30 kg/m2
  • NPO for at least 6 hours before the study

Exclusion Criteria:

  • Diabetes Mellitus
  • Chronic kidney disease or End-stage renal disease
  • Use of any medication that affects gastric secretion or emptying (Histamine 2 receptor antagonist eg. Ranitidine/Proton pump inhibitor eg. Omeprazole/Acid neutralization eg. Aluminium hydroxide/Prokinetic eg. Domperidone) within the past 24 hours
  • Gastroesophageal reflux disease
  • Pregnancy
  • History of upper gastrointestinal surgery
  • In diet program or use appetite suppressant drug (eg. Liraglutide, Naltrexone, Phentermine, Diethylpropion) within the past 24 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Water
  • Group C: will receive a carbohydrate drink of 400 ml (50 g of glucose prepared by nutrition division, same appearance and containing bottles of water)
  • Group W: will receive water 400 ml (prepared by nutrition division, Songklanagarind hospital, same appearance and containing bottles of carbohydrate drink) In both groups, the received 400-mL drink was consumed within 5 minutes.
  • Before drinking, baseline data (gastric residual volume, POCT glucose, degree of hunger, and thirst) will be evaluated.
  • Gastric ultrasound will be performed by the same Radiologist on each participant at 0, 30, 60, 90, 120 minutes
  • after drinking to evaluate the gastric residual volume and time to empty gastric antrum.
  • POCT glucose and degree of hunger and thirst are also assessed again at 120 minutes after drinking.
  • After completing one type of drinking, participants will be appointed again after 1 week later for doing the same protocol with another drinking.
Experimental: Preoperative carbohydrate drink
  • Group C: will receive a carbohydrate drink of 400 ml (50 g of glucose prepared by nutrition division, same appearance and containing bottles of water)
  • Group W: will receive water 400 ml (prepared by nutrition division, Songklanagarind hospital, same appearance and containing bottles of carbohydrate drink) In both groups, the received 400-mL drink was consumed within 5 minutes.
  • Before drinking, baseline data (gastric residual volume, POCT glucose, degree of hunger, and thirst) will be evaluated.
  • Gastric ultrasound will be performed by the same Radiologist on each participant at 0, 30, 60, 90, 120 minutes
  • after drinking to evaluate the gastric residual volume and time to empty gastric antrum.
  • POCT glucose and degree of hunger and thirst are also assessed again at 120 minutes after drinking.
  • After completing one type of drinking, participants will be appointed again after 1 week later for doing the same protocol with another drinking.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gastric residual volume
Time Frame: baseline and every 30 minutes until 2 hours after drinking
changes in gastric residual volume during 2 hours after drinking
baseline and every 30 minutes until 2 hours after drinking

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
time to empty gastric antrum
Time Frame: baseline and 120 minutes after drinking
baseline and 120 minutes after drinking
POCT glucose
Time Frame: baseline and 120 minutes after drinking
changes in glucose level after ingest carbohydrate drink or water
baseline and 120 minutes after drinking
thirst and hunger level
Time Frame: baseline and 120 minutes after drinking
thirst and hunger level will be evaluated by visual rating scale
baseline and 120 minutes after drinking

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chanatthee Kitsiripant, Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Anticipated)

May 31, 2023

Study Completion (Anticipated)

May 31, 2023

Study Registration Dates

First Submitted

April 9, 2023

First Submitted That Met QC Criteria

April 21, 2023

First Posted (Actual)

April 24, 2023

Study Record Updates

Last Update Posted (Actual)

April 24, 2023

Last Update Submitted That Met QC Criteria

April 21, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • REC.65-236-8-1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Preopertive drink

3
Subscribe